RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway ; volume:29 ; number:1 ; day:3 ; month:10 ; year:2023 ; pages:1-15 ; date:12.2023
Molecular medicine ; 29, Heft 1 (3.10.2023), 1-15, 12.2023
- Urheber
-
Wei, Zhun
Xia, Kezhou
Zheng, Di
Gong, Changtian
Guo, Weichun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s10020-023-00722-6
- URN
-
urn:nbn:de:101:1-2024020112353049666284
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wei, Zhun
- Xia, Kezhou
- Zheng, Di
- Gong, Changtian
- Guo, Weichun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Schisandrin B Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis Through PI3K/AKT/mTOR Pathway Mediated Autophagy
Correction: Schisandrin B Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis Through PI3K/AKT/mTOR Pathway Mediated Autophagy
Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
Chitosan oligosaccharide suppresses osteosarcoma malignancy by inhibiting CEMIP via the PI3K/AKT/mTOR pathway
SLC38A5 suppresses ferroptosis through glutamine-mediated activation of the PI3K/AKT/mTOR signaling in osteosarcoma
MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
ANK1 inhibits malignant progression of osteosarcoma by promoting ferroptosis
PENK inhibits osteosarcoma cell migration by activating the PI3K/Akt signaling pathway
Knockdown of RASD1 improves MASLD progression by inhibiting the PI3K/AKT/mTOR pathway
ACTL8 Promotes the Progression of Gastric Cancer Through PI3K/AKT/mTOR Signaling Pathway
MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway
IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways
Schisandrin B Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis Through PI3K/AKT/mTOR Pathway Mediated Autophagy
Correction: Schisandrin B Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis Through PI3K/AKT/mTOR Pathway Mediated Autophagy
Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
Chitosan oligosaccharide suppresses osteosarcoma malignancy by inhibiting CEMIP via the PI3K/AKT/mTOR pathway
SLC38A5 suppresses ferroptosis through glutamine-mediated activation of the PI3K/AKT/mTOR signaling in osteosarcoma
MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
ANK1 inhibits malignant progression of osteosarcoma by promoting ferroptosis
PENK inhibits osteosarcoma cell migration by activating the PI3K/Akt signaling pathway
Knockdown of RASD1 improves MASLD progression by inhibiting the PI3K/AKT/mTOR pathway
ACTL8 Promotes the Progression of Gastric Cancer Through PI3K/AKT/mTOR Signaling Pathway
MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway
IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways
Schisandrin B Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis Through PI3K/AKT/mTOR Pathway Mediated Autophagy
Correction: Schisandrin B Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis Through PI3K/AKT/mTOR Pathway Mediated Autophagy
Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
Chitosan oligosaccharide suppresses osteosarcoma malignancy by inhibiting CEMIP via the PI3K/AKT/mTOR pathway
SLC38A5 suppresses ferroptosis through glutamine-mediated activation of the PI3K/AKT/mTOR signaling in osteosarcoma
MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
ANK1 inhibits malignant progression of osteosarcoma by promoting ferroptosis
PENK inhibits osteosarcoma cell migration by activating the PI3K/Akt signaling pathway
Knockdown of RASD1 improves MASLD progression by inhibiting the PI3K/AKT/mTOR pathway
ACTL8 Promotes the Progression of Gastric Cancer Through PI3K/AKT/mTOR Signaling Pathway
MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway